Journal Article
B. W. Neuman, Stein, D. A., Kroeker, A. D., Paulino, A. D., Moulton, H. M., Iversen, P. L., and Buchmeier, M. J.,
“Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growth.”,
Journal of virology, vol. 78, no. 11, pp. 5891-9, 2004.
R. Burrer, Neuman, B. W., Ting, J. P. C., Stein, D. A., Moulton, H. M., Iversen, P. L., Kuhn, P., and Buchmeier, M. J.,
“Antiviral effects of antisense morpholino oligomers in murine coronavirus infection models.”,
Journal of virology, vol. 81, no. 11, pp. 5637-48, 2007.
M. H. Nelson, Stein, D. A., Kroeker, A. D., Hatlevig, S. A., Iversen, P. L., and Moulton, H. M.,
“Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.”,
Bioconjugate chemistry, vol. 16, no. 4, pp. 959-66, 2005.
B. Lebleu, Moulton, H. M., Abes, R., Ivanova, G. D., Abes, S., Stein, D. A., Iversen, P. L., Arzumanov, A. A., and Gait, M. J.,
“Cell penetrating peptide conjugates of steric block oligonucleotides.”,
Advanced drug delivery reviews, vol. 60, no. 4-5, pp. 517-29, 2008.
B. W. Neuman, Bederka, L. H., Stein, D. A., Ting, J. P. C., Moulton, H. M., and Buchmeier, M. J.,
“Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.”,
Antimicrobial agents and chemotherapy, vol. 55, no. 10, pp. 4631-8, 2011.
B. W. Neuman, Stein, D. A., Kroeker, A. D., Moulton, H. M., Bestwick, R. K., Iversen, P. L., and Buchmeier, M. J.,
“Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers.”,
Advances in experimental medicine and biology, vol. 581, pp. 567-71, 2006.
B. W. Neuman, Stein, D. A., Kroeker, A. D., Churchill, M. J., Kim, A. M., Kuhn, P., Dawson, P., Moulton, H. M., Bestwick, R. K., Iversen, P. L., and Buchmeier, M. J.,
“Inhibition, escape, and attenuated growth of severe acute respiratory syndrome coronavirus treated with antisense morpholino oligomers.”,
Journal of virology, vol. 79, no. 15, pp. 9665-76, 2005.
J. Yuan, Stein, D. A., Lim, T., Qiu, D., Coughlin, S., Liu, Z., Wang, Y., Blouch, R., Moulton, H. M., Iversen, P. L., and Yang, D.,
“Inhibition of coxsackievirus B3 in cell cultures and in mice by peptide-conjugated morpholino oligomers targeting the internal ribosome entry site.”,
Journal of virology, vol. 80, no. 23, pp. 11510-9, 2006.
M. Moerdyk-Schauwecker, Stein, D. A., Eide, K., Blouch, R. E., Bildfell, R. J., Iversen, P., and Jin, L.,
“Inhibition of HSV-1 ocular infection with morpholino oligomers targeting ICP0 and ICP27.”,
Antiviral research, vol. 84, no. 2, pp. 131-41, 2009.
C. Lupfer, Stein, D. A., Mourich, D. V., Tepper, S. E., Iversen, P. L., and Pastey, M.,
“Inhibition of influenza A H3N8 virus infections in mice by morpholino oligomers.”,
Archives of virology, vol. 153, no. 5, pp. 929-37, 2008.
Q. Ge, Pastey, M., Kobasa, D., Puthavathana, P., Lupfer, C., Bestwick, R. K., Iversen, P. L., Chen, J., and Stein, D. A.,
“Inhibition of multiple subtypes of influenza A virus in cell cultures with morpholino oligomers.”,
Antimicrobial agents and chemotherapy, vol. 50, no. 11, pp. 3724-33, 2006.
Y. - J. Zhang, Wang, K. - Y., Stein, D. A., Patel, D., Watkins, R., Moulton, H. M., Iversen, P. L., and Matson, D. O.,
“Inhibition of replication and transcription activator and latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus by morpholino oligomers.”,
Antiviral research, vol. 73, no. 1, pp. 12-23, 2007.
K. Eide, Moerdyk-Schauwecker, M., Stein, D. A., Bildfell, R. J., Koelle, D. M., and Jin, L.,
“Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.”,
Antiviral therapy, vol. 15, no. 8, pp. 1141-9, 2010.
R. Rajsbaum, Versteeg, G. A., Schmid, S., Maestre, A. M., Belicha-Villanueva, A., Martínez-Romero, C., Patel, J. R., Morrison, J., Pisanelli, G., Miorin, L., Laurent-Rolle, M., Moulton, H. M., Stein, D. A., Fernandez-Sesma, A., tenOever, B. R., and García-Sastre, A.,
“Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response.”,
Immunity, vol. 40, no. 6, pp. 880-95, 2014.